Baing, Mary Jane H.
HRN: 06-69-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2024
CEFUROXIME 1.5GM (VIAL)
04/25/2024
04/28/2024
IV
1.5 G
Q8
For Repeat CS,PROM
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes